Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Janux Therapeutics Inc (JANX) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Janx007, Janx013Prostate Cancer, Metastatic Prostate Cancer, Castration-Resistant Prostate Cancer (Crpc), Metastatic Castration-Resistant Prostate Cancer PatientsPhase IRecruitingPhase 1 Trial to Study JANX013 and JANX007 Combination in mCRPCSep 04, 2026―
Janx014Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Castration-Resistant Prostate CancerPhase IRecruitingStudy of JANX014 in Subjects With Metastatic Castration-Resistant Prostate CancerApr 16, 2026
Janx011AutoimmuneearlyPhase1RecruitingStudy of JANX011 in Healthy Adult Volunteers to Assess Safety and Tolerability.Dec 05, 2025
Janx008Non-small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma, Small Cell Lung Cancer, Renal Cell Carcinoma, Colorectal Carcinoma, Triple-Negative Breast Cancer, Squamous Cell Carcinoma Of The Head And NeckPhase IRecruitingStudy of JANX008 in Subjects With Advanced or Metastatic Solid Tumor MalignanciesMar 14, 2023
Darolutamide, Janx007Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Castration Resistant Prostatic CancerPhase IRecruitingStudy of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)Aug 25, 2022

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Janux Therapeutics, Inc. (JANX) have in its pipeline
Janux Therapeutics Inc JANX is currently developing the following drugs: Janx007, Janx013, Janx014, Janx011, Janx008, Darolutamide, Janx007. These drug candidates are in various stages of clinical development as the company works toward FDA approval.